More on CNSP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (11/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CNS Pharmaceuticals (NQ:CNSP)
Delayed: 5.82 +0.07 (1.22%)
Prev. Close $5.75  
Open$5.85 
52 Wk High$ 
52 Wk Low$ 
Day High$5.85 
Day Low$5.73 
P/E N/A  
EPS$ 
Volume18,332 

Friends, Peers and Foes (?): AKTX, AMIX, GRI, MBRX, NUWE (more...)

Sep 1, 2026 09:02 AM CNS Pharmaceuticals outlines oncology and neurology pipeline strategy
Sep 1, 2026 09:01 AM CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
Aug 27, 2026 09:02 AM CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference
Aug 25, 2026 05:24 PM Form DEFA14A CNS Pharmaceuticals,
Aug 21, 2026 05:15 PM Form DEF 14A CNS Pharmaceuticals, For: Sep 30
Aug 18, 2026 09:01 AM Form 4 CNS Pharmaceuticals, For: May 18 Filed by: Fisher Michal
Aug 18, 2026 09:00 AM Form 4 CNS Pharmaceuticals, For: Aug 14 Filed by: Levin Rami
Aug 18, 2026 09:00 AM Form 3 CNS Pharmaceuticals, For: May 04 Filed by: Fisher Michal
Aug 14, 2026 09:26 PM Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Ikarian Capital, LLC
Aug 12, 2026 08:01 AM CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
View All Articles

Entities mentioned with CNSP

View All Entities